168 related articles for article (PubMed ID: 36611797)
21. The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells.
Aichberger KJ; Mayerhofer M; Vales A; Krauth MT; Gleixner KV; Bilban M; Esterbauer H; Sonneck K; Florian S; Derdak S; Pickl WF; Agis H; Falus A; Sillaber C; Valent P
Blood; 2006 Nov; 108(10):3538-47. PubMed ID: 16849647
[TBL] [Abstract][Full Text] [Related]
22. Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy.
Gernez Y; Tirouvanziam R; Yu G; Ghosn EE; Reshamwala N; Nguyen T; Tsai M; Galli SJ; Herzenberg LA; Herzenberg LA; Nadeau KC
Int Arch Allergy Immunol; 2011; 154(4):318-27. PubMed ID: 20975283
[TBL] [Abstract][Full Text] [Related]
23. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation.
Hennersdorf F; Florian S; Jakob A; Baumgärtner K; Sonneck K; Nordheim A; Biedermann T; Valent P; Bühring HJ
Cell Res; 2005 May; 15(5):325-35. PubMed ID: 15916720
[TBL] [Abstract][Full Text] [Related]
24. Reliability of basophil activation test using CD203c expression in diagnosis of pollen allergy.
Özdemir SK; Güloğlu D; Sin BA; Elhan AH; Ikincioğulları A; Mısırlıgil Z
Am J Rhinol Allergy; 2011; 25(6):e225-31. PubMed ID: 22185730
[TBL] [Abstract][Full Text] [Related]
25. System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells.
Huang G; Yin Z; Wang X; Wen Z; Su R; Li C; Liu Y; Yang J; Hu H; Nie H; Zeng X; Fei J
Phytomedicine; 2023 Aug; 117():154918. PubMed ID: 37329755
[TBL] [Abstract][Full Text] [Related]
26. Adhesion molecule cross-linking and cytokine exposure modulate IgE- and non-IgE-dependent basophil activation.
Kalm F; Mansouri L; Russom A; Lundahl J; Nopp A
Immunology; 2021 Jan; 162(1):92-104. PubMed ID: 32955733
[TBL] [Abstract][Full Text] [Related]
27. CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation.
Sturm EM; Kranzelbinder B; Heinemann A; Groselj-Strele A; Aberer W; Sturm GJ
Cytometry B Clin Cytom; 2010 Sep; 78(5):308-18. PubMed ID: 20533392
[TBL] [Abstract][Full Text] [Related]
28. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
[TBL] [Abstract][Full Text] [Related]
29. The relationship between interleukin-3-like activity and basophil production in chronic myeloid leukemia patients.
Fishman P; Sredni B; Djaldetti M
Immunol Lett; 1991 Apr; 28(1):73-7. PubMed ID: 2071173
[TBL] [Abstract][Full Text] [Related]
30. CD203c expression on human basophils is associated with asthma exacerbation.
Ono E; Taniguchi M; Higashi N; Mita H; Kajiwara K; Yamaguchi H; Tatsuno S; Fukutomi Y; Tanimoto H; Sekiya K; Oshikata C; Tsuburai T; Tsurikisawa N; Otomo M; Maeda Y; Hasegawa M; Miyazaki E; Kumamoto T; Akiyama K
J Allergy Clin Immunol; 2010 Feb; 125(2):483-489.e3. PubMed ID: 20159259
[TBL] [Abstract][Full Text] [Related]
31. Optimizing of the basophil activation test: Comparison of different basophil identification markers.
Eberlein B; Hann R; Eyerich S; Pennino D; Ring J; Schmidt-Weber CB; Buters J
Cytometry B Clin Cytom; 2015; 88(3):183-9. PubMed ID: 25399741
[TBL] [Abstract][Full Text] [Related]
32. Marked improvement of the basophil activation test by detecting CD203c instead of CD63.
Boumiza R; Monneret G; Forissier MF; Savoye J; Gutowski MC; Powell WS; Bienvenu J
Clin Exp Allergy; 2003 Feb; 33(2):259-65. PubMed ID: 12580920
[TBL] [Abstract][Full Text] [Related]
33. MIP-1α/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice.
Baba T; Tanabe Y; Yoshikawa S; Yamanishi Y; Morishita S; Komatsu N; Karasuyama H; Hirao A; Mukaida N
Blood; 2016 May; 127(21):2607-17. PubMed ID: 27006388
[TBL] [Abstract][Full Text] [Related]
34. The expression of CD123 can decrease with basophil activation: implications for the gating strategy of the basophil activation test.
Santos AF; Bécares N; Stephens A; Turcanu V; Lack G
Clin Transl Allergy; 2016; 6():11. PubMed ID: 27042292
[TBL] [Abstract][Full Text] [Related]
35. KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors.
Corbin AS; O'Hare T; Gu Z; Kraft IL; Eiring AM; Khorashad JS; Pomicter AD; Zhang TY; Eide CA; Manley PW; Cortes JE; Druker BJ; Deininger MW
Cancer Res; 2013 Sep; 73(18):5775-86. PubMed ID: 23887971
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of basophil activation by histamine: a sensitive and reproducible model for the study of the biological activity of high dilutions.
Sainte-Laudy J; Belon P
Homeopathy; 2009 Oct; 98(4):186-97. PubMed ID: 19945674
[TBL] [Abstract][Full Text] [Related]
37. Targeted chronic myeloid leukemia therapy: seeking a cure.
Fausel C
J Manag Care Pharm; 2007 Oct; 13(8 Suppl A):8-12. PubMed ID: 17970609
[TBL] [Abstract][Full Text] [Related]
38. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
39. Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy.
Rohon P; Divoka M; Calabkova L; Mojzikova R; Katrincsakova B; Rusinakova Z; Lapcikova A; Raida L; Faber E; Jarosova M; Divoky V; Indrak K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Jun; 155(2):187-90. PubMed ID: 21804629
[TBL] [Abstract][Full Text] [Related]
40. Isolation of transcriptionally active umbilical cord blood-derived basophils expressing Fc epsilon RI, HLA-DR and CD203c.
Reimer JM; Magnusson S; Juremalm M; Nilsson G; Hellman L; Wernersson S
Allergy; 2006 Sep; 61(9):1063-70. PubMed ID: 16918508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
